Established in 2006, the Guided Therapeutics Program (GTx) at the University Health Network is a collaboration of surgeons, medical imaging specialists, radiation oncologists, interventional radiologists, physicists, nanotechnology engineers and biomedical engineers all focused on the research, development and clinical implementation of innovative technologies to enable novel cancer diagnostics and therapeutics. The current scope of the program includes research and development in pre-clinical and translational/clinical settings.
The GTx program has coordinated the planning and implementation of image-guided resources across UHN. This includes the GTx-Lab with 1 fully equipped operating room, the GTx-OR and GTx-MR suite at the Toronto General Hospital/UHN.
The facility is led by:
- Dr. Jonathan Irish (surgical oncology)
- Dr. David Jaffray (radiation therapy)
- Dr. Walter Kucharczyk (medical imaging)
- Dr. Kazuhiro Yasufuku (thoracic surgery)
- Dr. Kieran Murphy (interventional radiology)
- Dr. Michael Tymianski (neurosurgery)
- Dr. John Trachtenberg (prostate interventions)
- Dr. Michael Jewett (renal interventions)
- Unique multi-disciplinary research collaboration among scientists, engineers and clinicians with a shared vision toward revolutionary cancer interventions
- High-precision, image-guided interventions (including surgery, radiotherapy and cell-based therapies)
- Operating room
- GTx-Lab: basic research and development of guidance technologies; preclinical models testing; preclinical Cone-Beam CT imaging
- GTx-OR: translational research image-guided OR, focusing on head and neck, chest and breast procedures with dual energy CT scanner and robotically controlled Cone-beam CT and fluoroscopy imaging
- MRI-Interventional Suite: translational research image-guided OR, focusing on prostate and advanced applications of HIFU with 1.5T MRI
- Image-guidance technologiesMRI, CT, cone-beam CT, ultrasound, optical fluorescence, HIFU, real-time tracking and navigation, deformable image registration.
Research, development and translation of advanced imaging and guidance technologies in therapeutic interventions, including surgery, radiation therapy and interventional radiology.
Primary focus is on cancer interventions. Mandate is toward creation and translation of new technologies and therapeutic techniques, with a strong emphasis on research.
Dr. Robert Weersink
Princess Margaret Cancer Research Tower
110 College St, Room 7-1001
Toronto, Ontario, M5G 2C4